跳至主要内容
临床试验/CTRI/2020/03/024185
CTRI/2020/03/024185尚未招募2 期

Evaluation of efficacy and safety of Javetri (Myristica fragrans) in patients of dyslipidaemia

School of Unani Medical Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Known cases of dyslipidemia with any one of the following:
  • 1. Total Cholesterol Level >200 mg/dl
  • 2. Low Density Lipoprotein Cholesterol Level >130mg/dl <160 mg/dl (NCEP ATP III)
  • 3. Serum Triglycerides Level >150 mg/dl
  • 4. High Density Lipoprotein <40mg/dl

排除标准

  • 1. Low Density Lipoprotein Cholesterol Level >160mg/dl.
  • 2. Serum Triglycerides Level >= 1000mg/dl.
  • 3. Pregnant and Lactating women
  • 4. Patients suffering with CKD, CAD, CLD or uncontrolled DM, Thyroid Disorder.
  • 5. Patient having immune-compromised status.
  • 6. Patient using lipid lowering drugs or dietary supplements with the last 3 weeks.
  • 7. Oral contraceptives & Corticosteroids.
  • 8. Use of Alcohol or any other drug abuse.
  • 9. Neurological disorders like epilepsy or psychiatric disorders.
  • 10. Patient having history of Pancreatitis.
  • 11. Terminally ill Patient.

研究者

发起方
School of Unani Medical Education and Research

相似试验